Cargando…
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
Bladder cancer (BC) is a heterogeneous disease that characterized by genomic instability and a high mutation rate. Heterogeneity in tumor may partially explain the diversity of responses to targeted therapies and the various clinical outcomes. A combination of cytology and cystoscopy is the standard...
Autores principales: | Huang, Hai‐Ming, Li, Hai‐Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896752/ https://www.ncbi.nlm.nih.gov/pubmed/33377623 http://dx.doi.org/10.1002/cac2.12129 |
Ejemplares similares
-
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
por: Russano, Marco, et al.
Publicado: (2020) -
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018) -
Liquid biopsies for bladder cancer
por: Ward, Douglas G., et al.
Publicado: (2017) -
Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance
por: Kang, Minyong, et al.
Publicado: (2017) -
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
por: Russano, Marco, et al.
Publicado: (2020)